Back Login for AI Analysis

    REVBW (STOCKS)

    Revelation Biosciences, Inc. Warrant

    $0.010200
    +0.000000 (+0.00%)
    Prev close: $0.010200
    Company Information
    Exchange
    XNAS
    Sector
    Health Technology
    Industry
    Biotechnology
    CEO
    James M. Rolke
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    —
    Employees
    9
    P/E (TTM)
    —
    P/B (TTM)
    —
    Dividend Yield
    —
    Technical Indicators
    SMA 10
    —
    SMA 20
    —
    SMA 50
    —
    EMA 9
    —
    EMA 21
    —
    RSI
    —
    MACD State
    —
    Recent News

    No recent news found for this ticker.

    Financial Statements
    TTM (Mar 2026)
    Revenues $0.00
    Nonoperating Income/Loss $196.71K
    Operating Expenses $10.07M
    Research and Development $4.58M
    Other Operating Expenses $5.49M
    Operating Income/Loss -$10.07M
    Income/Loss From Continuing Operations After Tax -$9.87M
    Income/Loss From Continuing Operations Before Tax -$9.87M
    Net Income/Loss -$9.87M
    Net Income/Loss Attributable To Noncontrolling Interest $0.00
    Net Income/Loss Attributable To Parent -$9.87M
    Net Income/Loss Available To Common Stockholders, Basic -$21.50M
    Participating Securities, Distributed And Undistributed Earnings/Loss, Basic $8.45M
    Preferred Stock Dividends And Other Adjustments $8.45M
    Basic Earnings Per Share -$25.68
    Diluted Earnings Per Share -$25.68
    Basic Average Shares 6,010,337
    Diluted Average Shares 6,010,337
    Assets $15.04M
    Current Assets $14.21M
    Noncurrent Assets $838.25K
    Fixed Assets $140.72K
    Other Non-current Assets $697.53K
    Liabilities $2.06M
    Current Liabilities $1.42M
    Accounts Payable $828.20K
    Other Current Liabilities $588.94K
    Noncurrent Liabilities $638.18K
    Equity $12.99M
    Equity Attributable To Noncontrolling Interest $0.00
    Equity Attributable To Parent $12.99M
    Liabilities And Equity $15.04M
    Net Cash Flow From Operating Activities -$8.69M
    Net Cash Flow From Operating Activities, Continuing -$8.69M
    Net Cash Flow $6.21M
    Net Cash Flow, Continuing $6.21M
    Comprehensive Income/Loss -$9.87M
    Comprehensive Income/Loss Attributable To Noncontrolling Interest $0.00
    Comprehensive Income/Loss Attributable To Parent -$9.87M
    Other Comprehensive Income/Loss $0.00